Thromboembolic events during continuous vasopressin infusions: A retrospective evaluation

Keyphrases

• Retrospective Survey 100%
• Vasopressin 100%
• Venous Thromboembolism 72%
• Catecholamines 27%
• Shock 27%
• Clinical Setting 9%
• Intensive Care Unit 9%
• Patients with Diabetes 9%
• Single Center 9%
• Risk Factors 9%
• Between-group 9%
• Modeling Approach 9%
• Hypotension 9%
• Tertiary Care Hospital 9%
• Logistic Regression 9%
• Platelet Aggregation 9%
• Coagulant 9%
• Pulmonary Embolism 9%
• Effect Modifier 9%
• Von Willebrand Factor 9%
• Potential Confounders 9%
• No Significant Difference 9%
• Doppler Ultrasound 9%
• Deep Vein Thrombosis 9%
• Diabetes Insipidus 9%
• Hemodynamic Support 9%
• Variceal Hemorrhage 9%
• Adjusting for Covariates 9%
• Crude Incidence 9%
• Risk Types 9%
• Discharge Records 9%
• Shock Therapy 9%
• Spiral Computed Tomography 9%
• Risk Factor Modeling 9%

Medicine and Dentistry

• Thromboembolism 100%
• Infusion 100%
• Vasopressin 100%
• Venous Thromboembolism 72%
• Catecholamine 27%
• Arm 27%
• Intensive Care Unit 9%
• Bleeding 9%
• Patient with Diabetes 9%
• Spiral Computed Tomography 9%
• Logistic Regression Analysis 9%
• Thrombocyte Aggregation 9%
• Cohort Analysis 9%
• Coagulating Agent 9%
• Pulmonary Embolism 9%
• Tertiary Care 9%
• Hypotension 9%
• Von Willebrand Factor 9%
• Deep Vein Thrombosis 9%
• Doppler Flowmetry 9%
• Diabetes Insipidus 9%
• Hemodynamic Support 9%
• Blood Clotting Factor 8 9%
• Doppler Ultrasound 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Thromboembolism 100%
• Vasopressin 100%
• Venous Thromboembolism 72%
• Catecholamine 27%
• Bleeding 9%
• Coagulating Agent 9%
• Cohort Study 9%
• Lung Embolism 9%
• Blood Clotting Factor 8 9%
• Von Willebrand Factor 9%
• Hypotension 9%
• Deep Vein Thrombosis 9%
• Diabetes Insipidus 9%